Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Role of Nox2 in diabetic kidney disease.
Authors
You YH, Okada S, Ly S, Jandeleit-Dahm K, Barit D, Namikoshi T, Sharma K
Submitted By
Kumar Sharma on 7/10/2013
Status
Published
Journal
American journal of physiology. Renal physiology
Year
2013
Date Published
4/1/2013
Volume : Pages
304 : F840 - F848
PubMed Reference
23389458
Abstract
NADPH oxidase (Nox) isoforms have been implicated in contributing to diabetic
microvascular complications, but the functional role of individual isoforms in
diabetic kidney are unclear. Nox2, in particular, is highly expressed in
phagocytes and may play a key inflammatory role in diabetic kidney disease. To
determine the role of Nox2, we evaluated kidney function and pathology in
wild-type (WT; C57BL/6) and Nox2 knockout (KO) mice with type 1 diabetes.
Diabetes was induced in male Nox2 KO and WT mice with a multiple low-dose
streptozotocin protocol. Groups were studied for kidney disease after 8 and 20
wk of diabetes. Hyperglycemia and body weights were similar in WT and Nox2 KO
diabetic mice. All functional and structural features of early and later stage
diabetic kidney disease (albuminuria, mesangial matrix, tubulointerstitial
disease, and gene expression of matrix and transforming growth factor-ß) were
similar in both diabetic groups compared with their respective nondiabetic
groups, except for reduction of macrophage infiltration and monocyte
chemoattractant protein-1 in the diabetic Nox2 KO mice. Systolic blood pressure
by telemetry was surprisingly increased in Nox2 KO mice; however, the systolic
blood pressure was reduced in the diabetic WT and Nox2 KO mice by tail-cuff.
Interestingly, diabetic Nox2 KO mice had marked upregulation of renal Nox4 at
both the glomerular and cortical levels. The present results demonstrate that
lack of Nox2 does not protect against diabetic kidney disease in type 1
diabetes, despite a reduction in macrophage infiltration. The lack of
renoprotection may be due to upregulation of renal Nox4.
Investigators with authorship
Name
Institution
Kumar Sharma
University of California San Diego
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!